Meet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
Reliable commercial manufacturing built on proven processes, operational excellence, and regulatory rigor, ensuring consistent quality and long-term market supply.
Moving into commercial manufacturing requires more than increasing batch sizes. Manufacturers must ensure that validated processes continue to perform consistently, product quality remains uncompromised, and supply can reliably meet market demand over the long term.
With over 40 years of experience in complex API manufacturing and 1226 kL of reactor capacity across three cGMP facilities, we provide the operational scale, technical expertise, and manufacturing infrastructure needed to support commercial small molecule APIs. Our teams work closely with customers to transfer validated processes into commercial operations while maintaining continuity of process knowledge and manufacturing performance.
Commercial manufacturing depends on processes that consistently deliver the required quality at scale. Through process validation, continued process monitoring, and lifecycle management activities, we help establish robust manufacturing controls that support reliable execution, regulatory compliance, and long-term supply continuity throughout the commercial lifecycle.
Supported by over 1226 kL of total reactor capacity across three cGMP manufacturing facilities, our commercial manufacturing network is designed to support product launches and long-term market supply requirements worldwide.
Our scientists bring deep expertise in complex chemistry and scalable manufacturing. Start a conversation to explore how our drug development CDMO capabilities can support your molecule from early development through commercial supply.
Quick answers to help you better understand our CDMO capabilities and approach.
Still Have Questions? Contact UsCommercial API manufacturing is the production of active pharmaceutical ingredients for approved products intended for market supply. It requires validated processes, established quality systems, and the ability to consistently manufacture product at commercial scale.
Clinical manufacturing supports investigational products used in clinical trials, while commercial manufacturing supports approved products intended for long-term market supply. Commercial manufacturing relies on validated processes, larger production volumes, and established lifecycle management strategies.
Process validation demonstrates that a manufacturing process can consistently produce API meeting predefined quality requirements under routine commercial operating conditions. It is a critical step in establishing commercial readiness.
Supply continuity is supported through validated manufacturing processes, robust quality systems, lifecycle management activities, and manufacturing infrastructure designed to accommodate long-term commercial production requirements.
Key considerations include manufacturing experience, commercial-scale capacity, regulatory compliance, supply reliability, process validation expertise, and the ability to support long-term lifecycle management.
Yes. Commercial API manufacturing must support global regulatory expectations, product quality requirements, and supply obligations across different markets while maintaining consistent manufacturing performance.
Commercial manufacturing is supported through ongoing process monitoring, lifecycle management, continuous improvement initiatives, and manufacturing strategies designed to maintain product quality and supply reliability over time.
